Enhancing Shared Decision-making to Guide Care for People With Dementia and Diabetes

NCT ID
NCT05643144
Registry status
Recruiting
Study type
Interventional
Phase
Not applicable
Sponsor
Indiana University
Conditions
Alzheimer's Disease (Incl Subtypes), Dementia, Diabetes, Hypoglycemia

Overview

ClinicalTrials.gov lists this study as Recruiting.

Official title: Enhancing Shared Decision-making to Prompt and Guide Individualized Care for People With Alzheimer's Disease and Diabetes

Enrollment: 62 participants (Estimated).

What is being studied

  • Intervention: Blood Chemical Analysis
  • Intervention: Clinical Chemistry Tests
  • Intervention: Clinical Laboratory Techniques
  • Device: Continuous Glucose Monitoring
  • Intervention: Continuous Glucose Monitoring
  • Intervention: Diagnosis
  • Intervention: Diagnostic Techniques and Procedures
  • Intervention: Diagnostic Techniques, Endocrine
  • Intervention: Investigative Techniques
  • Intervention: Monitoring, Physiologic

Who may be eligible

Ages
65 Years to no maximum
Sex
All
Healthy volunteers accepted
No

ClinicalTrials.gov lists the following eligibility criteria.

Patient-Caregiver Dyad Inclusion Criteria: * patient must have dual diagnosis of MCI or ADRD and diabetes (DM) * patient must have active prescriptions for DM * patient must have had at least one visit to an Eskenazi or IU Health primary care clinic within 12 months * patient must be able to provide assent and have a legally authorized representative (LAR) consent on their behalf if patient lacks capacity to consent * patient must have a caregiver aged 18 years or older who interacts daily, or almost daily, with the patient * patient and caregiver must both speak English * patient and caregiver must both reside in the community * dyad must have internet access Patient-Caregiver Dyad Exclusion Criteria: * patient has terminal illness * use of an automated insulin delivery system * patient is receiving dialysis * patient is taking ascorbic acid during monitoring period * patient has existing implanted medical devices * patient has a bleeding disorder * patient has a pre-existing arm skin lesions * patient has an allergy to medical adhesive or isopropyl alcohol * patient has plans for imaging or diathermy treatment during the study period

Study locations

1 study location is listed.

Recruiting site status is explicitly provided for 1 location; 1 is listed as Recruiting.

Countries: United States

  • Indiana, United States: 1

Sample of listed locations

  • Eskenazi Health — Indianapolis, Indiana, 46202, United States — Recruiting

Study details

Start date
September 29, 2026
Primary completion date
June 30, 2027
Completion date
June 30, 2027
First posted
December 8, 2022
Collaborators
National Institute on Aging (NIA)

Source and update information

Source
ClinicalTrials.gov
NCT ID
NCT05643144
Registry last updated
October 5, 2026
QualifiedStudies registry data refreshed
October 12, 2026
QualifiedStudies record fetched
October 12, 2026

View NCT05643144 on ClinicalTrials.gov

Trial information can change. Confirm current study details with the study team or the registry.

About joining clinical research

Find clinical trials you may match with

QualifiedStudies can help you search for research opportunities related to your health. Availability of this specific study through QualifiedStudies has not been established.

Find clinical trials you may match with | Clinical trial FAQ